Lyell Immunopharma

Lyell is an immuno-oncology company dedicated to reprogramming T cells to achieve curative therapies for solid tumors. The company takes a deliberate approach to solving what it believes to be the major barriers to successful adoptive T cell therapy: T cell exhaustion and loss of durable stemness, w... Read more

Industries

Biotechnology, Therapeutics

Headquarters

South San Francisco, United States

Stage

Series C

Employees

201-500

Links

Org chart

President & CEO

Collapse

Chief Medical Officer & Head of Development

Chief Information Officer

Chief Operating Officer

Chief Scientific Officer

Chief Financial Officer

Chief People Officer

Rahsaan W. Thompson

Chief Legal Officer

Teams

View all

Board of Directors

9 members

Leadership Team

8 members

CEO and Executive Team

7 members

Founding Team

1 members

Discover similar companies

Techstars

New York, United States · Pre Seed

DoiT International

Santa Clara, United States · Series A

Veevart

Coral Gables, United States

Okcoin

San Francisco, United States · Series B

Springboard Collaborative

Philadelphia, United States

Miami Dolphins

Miami Gardens, United States

Course Hero

Redwood City, United States · Venture

Harvard University

Cambridge, United States

DoorDash

San Francisco, United States · IPO

Marketing Wing

Mount Pleasant, United States

Ogilvy

New York, United States

Informatica

Redwood City, United States

Two candidates

The Org
helps you hire
great candidates

It takes less than ten minutes to set up your company page.
It’s free to use - try it out today.